FdaApplication
ANDA 216608
Identifiers
- fda_app_no: ANDA216608
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2024-12-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
2 products